Avantax Planning Partners’s AnaptysBio ANAB Stock Holding History

Avantax Planning Partners’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-75	Closed	-$7K	–	323
2018 Q3	$7K	Buy	+75	New	+$6.22K	﹤0.01%	961
2018 Q2	–	Sell	-75	Closed	-$8K	–	300
2018 Q1	$8K	Buy	+75	New	+$8.45K	﹤0.01%	1136

Other funds holding ANAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Avantax Planning Partners's ANAB Position: Q4 2018 in Review

Avantax Planning Partners sold out of AnaptysBio (ANAB) in Q4 2018, closing a stake of 75 shares — an estimated $7K sold.

Avantax Planning Partners first reported a position in ANAB in Q1 2018 and held it in 2 quarters. The position peaked at $8K in Q1 2018. 121 funds tracked by Wall St. Rank hold ANAB as of Q4 2018.

Avantax Planning Partners reported no remaining AnaptysBio position as of Q4 2018 after selling out during the quarter.
Avantax Planning Partners sold 75 AnaptysBio shares in Q4 2018, an estimated $7K.
Avantax Planning Partners first reported a position in AnaptysBio in Q1 2018 and held it in 2 quarters.
Avantax Planning Partners's AnaptysBio position peaked at $8K in Q1 2018.
121 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2018.

Based on Avantax Planning Partners's 13F filing for Q4 2018, filed 14 Feb 2019.